In vitro assay and GC-MS profiling of Proteus sp.EKWG2I3 isolate obtained from Echinops kebericho Mesfin: A traditional medicinal plant
This study identifies the endophytic bacterium *Proteus* sp. EKWG2I3 from the medicinal plant *Echinops kebericho* as a promising source of bioactive compounds, demonstrating significant *in vitro* antibacterial and antioxidant activities alongside the identification of methyl phenylacetate and pentanoic acid methyl ester as its major constituents via GC-MS profiling.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine a tiny, invisible world living inside the roots of a special Ethiopian plant called Echinops kebericho. For years, scientists have known this plant is a traditional medicine, but they mostly looked at the plant itself. This study decided to peek inside the plant's "house" to see who the invisible roommates were. They found a bacterial tenant named Proteus sp. EKWG2I3, and they wanted to see if this little roommate had any hidden superpowers.
The Superpower Hunt
The researchers treated this bacterium like a detective looking for clues. First, they checked if the bacteria could build "biofilms" (sticky forts that help bacteria stick to roots) and if it could produce a special enzyme called ACC deaminase (a tool that helps plants handle stress). Out of all the bacteria they found, Proteus sp. EKWG2I3 was a champion: it built strong biofilms and made the enzyme.
To make sure they knew exactly who they were dealing with, they ran a DNA test (16S rRNA sequencing). The results were a near-perfect match: this bacterium is 99.91% similar to a known type called Proteus mirabilis. It's like finding a twin who shares almost every single family trait.
The Chemical Treasure Chest
Next, the scientists asked: "What kind of chemical gadgets does this bacterium carry?" They took a sample of the bacteria and ran it through a machine called GC-MS, which acts like a high-tech metal detector for chemicals.
The machine found a treasure chest of compounds. The biggest find was methyl phenylacetate, which made up 38.49% of the mix. The second biggest was pentanoic acid, methyl ester at 12.71%. The paper suggests these chemicals are the "weapons" the bacterium uses to fight off bad guys.
Fighting the Bad Guys (Antibacterial Test)
The team then put these bacterial chemicals to the test against four different types of "bad guy" bacteria (including E. coli). They used a method where they placed the chemical extract on a plate of bacteria to see if it could stop them from growing.
The results were promising but specific:
- Against E. coli, the extract created a clear zone of inhibition (a safety bubble where bacteria couldn't grow) measuring 15 ± 0 mm.
- Against P. aeruginosa, the safety bubble was smaller, at 10 ± 0.01 mm.
- The paper notes that while this is effective, it wasn't as strong as the standard antibiotic drug Ciprofloxacin, which created a 21 ± 0.05 mm zone against E. coli.
The Rust-Busting Power (Antioxidant Test)
Free radicals are like tiny rust particles in our bodies that cause damage. The researchers tested if the bacterial extract could "rust-proof" these particles using a test called DPPH.
The results showed the extract was a strong rust-buster. At a concentration of 1000 µg/mL, it stopped 88.13 ± 0.1% of the free radicals. To measure how strong it was, they calculated an IC50 value of 11.98 µg/mL. This number means it took only 11.98 µg/mL of the extract to stop half the free radicals. For comparison, the standard rust-buster, Ascorbic acid (Vitamin C), had an IC50 of 3.49 µg/mL, meaning the vitamin was stronger, but the bacterial extract still showed "potent" potential.
The Bottom Line
The paper doesn't claim this is a miracle cure or a finished medicine. Instead, it suggests that this specific bacterium, living inside the Echinops kebericho plant, is a potential source of bioactive compounds. It suggests that these compounds could help fight drug-resistant diseases in the future, but the authors clearly state that more work is needed to isolate the pure compounds and understand exactly how they work.
In short: A tiny bacterial roommate in an Ethiopian plant has been identified, its DNA confirmed, and its chemical toolkit measured. It shows notable antibacterial activity and potent antioxidant potential, offering a new lead for scientists to follow in the hunt for new medicines.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.